The original article, published on 6 December 2024, examined a class of cement-free or cement-reduced construction materials known as geopolymer concrete. Conventional Portland cement production releases substantial quantities of carbon dioxide because limestone must be heated to high temperatures and chemically decomposed. Geopolymers instead use aluminosilicate-rich materials, such as industrial by-products or other mineral sources, activated with alkaline solutions. During curing, dissolved silicon and aluminium species reorganize into a three-dimensional aluminosilicate network. That network can bind aggregates and develop mechanical strength, although its performance depends strongly on precursor chemistry, activator concentration, water content, curing conditions and the microstructure formed during reaction.

The study focused on two nanoscale additives: graphene oxide and nanozirconia. Graphene oxide consists of atomically thin carbon sheets decorated with oxygen-containing chemical groups. Those groups can improve dispersion in water-based mixtures and provide sites for interaction with the geopolymer gel. In principle, well-dispersed graphene oxide could bridge microscopic cracks, refine pores and increase resistance to mechanical damage. Nanozirconia, composed of extremely small particles of zirconium dioxide, is chemically stable and mechanically hard. Added to a cementitious or geopolymeric matrix, it might act as a reinforcing filler, occupy voids and alter the interface between aggregates and the binder. Such mechanisms are plausible, but they must be demonstrated through reproducible testing rather than inferred from attractive images or isolated strength measurements.

Microscopy was central to the paper’s evidence. Scanning electron microscopy, or SEM, produces high-magnification images by scanning a focused electron beam across a specimen and recording signals generated from the interaction between electrons and the material. Depending on the detector, the resulting image can reveal surface texture, cracks, pores, particles and the morphology of reaction products. For geopolymer research, SEM images are often used to support claims about a dense binder, improved particle packing or the formation of a more continuous gel. Yet SEM images are not automatically unique fingerprints of a sample’s behaviour. Magnification, contrast, cropping, rotation and image processing can all affect how a structure appears, which is why researchers must retain raw files, document acquisition conditions and make comparisons across independently prepared specimens.

The editors reported three specific concerns about the figures. Figure 1a appeared to overlap with Figure 11 of a separate cited work, while Figure 11d appeared to overlap with Figure 3d of another cited work. The retraction notice also states that Figures 13d and 14b appeared to overlap after rotation. These observations do not merely involve images that look generally similar because they depict comparable materials; the notice describes apparent overlap in particular figures, including an instance in which rotation was involved. In a materials-science paper, a duplicated or reused micrograph can misrepresent the morphology of a different specimen, treatment or test condition. That can undermine the chain of evidence connecting a formulation to a claimed improvement in strength, durability or chemical performance.

The notice raised a second issue involving energy-dispersive X-ray spectroscopy, or EDX. EDX is commonly attached to an SEM and measures characteristic X-rays emitted when the electron beam excites atoms in a sample. Because each element produces a distinctive set of X-ray energies, the technique can help identify the elements present and estimate their relative abundance. In geopolymer studies, EDX may be used to examine distributions of silicon, aluminium, oxygen, zirconium or other elements and to support interpretations of reaction products or additive incorporation. The editors said that the background noise in the EDX plots in Figure 1 showed repetitive patterns. Background noise is expected in spectroscopy, but suspiciously repeated structures can raise questions about whether a signal was independently measured, copied, processed or generated through an inappropriate workflow.

The absence of raw data made those concerns impossible for the editors to resolve. Raw SEM and EDX files can contain information that is not visible in a published figure, including acquisition parameters, detector settings, scale calibration, sample identifiers and the unprocessed signal. Investigators can compare those files with the displayed panels, inspect whether an image has been rotated or reused, and determine whether spectral features arise from the specimen or from data handling. Without the underlying records, an editor may be unable to distinguish an honest figure-preparation error from a more serious problem affecting the reliability of the results. The retraction notice does not assign a specific cause for the apparent overlaps or repetitive patterns; it states instead that the unresolved concerns led the editors to withdraw confidence in the presented data.

That distinction matters because the original paper’s subject sits at the intersection of nanomaterials engineering and infrastructure research, fields in which experimental claims can influence subsequent formulations and testing programs. If graphene oxide or nanozirconia appears to improve compressive strength, crack resistance, water absorption or chemical durability, later researchers may use those reported proportions as starting points. Engineers may also cite microstructural evidence when assessing whether a material can withstand freeze-thaw cycles, aggressive chemicals, moisture movement or long-term loading. A compromised image does not automatically prove that every mechanical measurement is wrong, but it weakens the support for the interpretation and makes it difficult to know which conclusions, if any, remain dependable.

Geopolymer concrete research is particularly sensitive to microstructural interpretation because its properties emerge from several overlapping scales. At the molecular and nanometre scales, alkaline activation dissolves portions of the precursor and forms binding gels. At larger scales, unreacted particles, pores, interfaces and cracks govern transport and failure. Water can move through connected pores, carrying dissolved ions that accelerate degradation or trigger further reactions. Nanoparticles may alter nucleation, packing and gel connectivity, but their effects depend on dispersion. Graphene oxide can restack into sheets if poorly mixed, while nanozirconia can agglomerate into clusters that create defects rather than reinforcement. A credible claim therefore requires more than a visually dense SEM field: it calls for carefully controlled mixtures, replicated specimens, transparent mechanical and durability data, and analytical results that can be independently checked.

The retraction does not establish that graphene oxide, nanozirconia or geopolymer concrete cannot be useful. Instead, it removes one published study as a reliable basis for judging the particular experimental and theoretical claims it presented. The episode highlights why data stewardship is as important as novelty in fast-moving materials research. Researchers need to preserve original microscopy files, complete spectra, laboratory logs, specimen histories and statistical records, while journals and institutions need procedures that allow questionable images to be examined efficiently. Independent replication remains essential, especially when a proposed additive is promoted as a way to improve both performance and sustainability. For readers, the most consequential result of the notice is not a verdict on nanomodified concrete as a technology, but a warning that promising engineering narratives must rest on evidence that remains traceable from raw measurement to published conclusion.

Cancer’s complexity and heterogeneity have long frustrated efforts to develop therapies that seamlessly target malignant cells without collateral damage to healthy tissues. Traditional chemotherapy agents, although potent, often lack specificity, resulting in systemic toxicity and limited therapeutic windows. To overcome these barriers, the research community has increasingly turned to nanotechnology, exploring the potential of engineered nanomaterials that can navigate the biological maze with greater precision. Among these, graphene oxide (GO), a two-dimensional carbon-based nanomaterial derived from graphite, stands out due to its exceptional structural characteristics, high surface area, and intrinsic ability to accumulate in tumor tissues via the enhanced permeability and retention (EPR) effect. Yet, its clinical translation has been hampered by rapid clearance mediated by the immune system, which identifies and eliminates these materials from circulation before they reach the tumor site.

This challenge motivated Professor Nishina’s team to engineer a novel graphene oxide nanocarrier with a “charge-reversible” surface that tactically evades immune surveillance in the bloodstream while activating its tumor-targeting properties within the acidic tumor environment. The key innovation lies in grafting hyperbranched amino-rich polyglycerol (hPGNH₂) onto the graphene oxide sheets and then functionalizing this composite with dimethylmaleic anhydride (DMMA). This chemical modification confers pH-sensitive charge conversion: at physiological pH (~7.4), the surface remains negatively charged, minimizing protein adsorption and immune recognition. However, upon encountering the slightly acidic milieu typical of tumor tissues (pH ~6.5 or lower), the surface charge switches to positive, enhancing electrostatic interactions with the negatively charged cell membranes of cancer cells, thereby promoting cellular internalization.

A critical aspect of this study was the systematic evaluation of three GOPG-DMMA nanomaterials differentiated by the density of surface amino groups, labeled GOPGNH115, GOPGNH60, and GOPGNH30. These variants allowed the researchers to fine-tune the balance between immune evasion and tumor targeting. Through extensive in vitro and in vivo experimentation, GOPGNH60-DMMA emerged as the optimal candidate due to its finely calibrated positive charge in acidic conditions and minimized nonspecific interactions in the bloodstream. This equilibrium led to higher tumor accumulation and improved cell uptake in murine cancer models, with significantly reduced off-target effects compared to the other variants.

The dynamic nanobiointerface engineered in this material represents a paradigm shift in the design of pH-responsive drug carriers. By modulating the physicochemical properties of the nanomaterial post-administration, the researchers could strategically dictate its biological fate. The implications extend beyond targeted delivery; the capacity to direct nanocarriers into specific acidic intracellular organelles such as lysosomes and endosomes opens avenues for next-generation therapies that act precisely where their payloads are most effective, potentially overcoming multidrug resistance and enhancing therapeutic indices.

Dr. Zou reflects on the broader significance of these findings: precise control over nanomaterial surface chemistry in response to physiological stimuli paves the way for “theranostic” platforms—integrated systems that combine diagnostics with therapeutics. Such dual-function nanocarriers could simultaneously visualize, monitor, and treat tumors in real time, dramatically improving personalized medicine approaches. This study marks a milestone in the iterative refinement of smart nanomedicines, showcasing how interdisciplinary collaboration between material science, chemistry, and biology can yield transformative medical technologies.

Strategically, this research is embedded within an ambitious international partnership, the IRP C3M program initiated in 2025 between Okayama University and the French National Centre for Scientific Research (CNRS). The program endeavors to push the frontiers of nanomaterials engineered for health applications, optimizing biocompatibility, targeting specificity, and functional versatility. Continued investigation into the molecular mechanisms governing nanomaterial-protein and nanomaterial-cell interactions is expected to deepen understanding and fuel the design of even more sophisticated carriers.

Technical challenges remain, particularly the necessity to emulate complex human tumor microenvironments in animal models and ensure that laboratory efficacy can be translated safely and effectively to clinical settings. Nonetheless, the demonstration that surface charge can be modulated dynamically and reversibly in vivo without eliciting significant immune responses or systemic toxicity suggests strong translational potential. These findings illuminate a clear path toward developing nanomedicines capable of intelligent decision-making, a characteristic integral to the future of personalized oncological therapy.

Professor Nishina’s contributions to the field extend beyond this study, as his multidisciplinary expertise in nanocarbons and biomedical applications informs a portfolio of research aimed at harnessing carbon nanomaterials for catalysis, energy devices, and, crucially, biomedicine. With over 210 peer-reviewed publications, multiple patents, and collaborations spanning the globe, his leadership underscores the vitality of convergent science in solving pressing healthcare challenges.

The study exemplifies the power of precise chemical engineering in redefining drug delivery modalities. By intercepting the critical balance between immune evasion and tumor penetration, nanomaterials like GOPG-DMMA herald a new generation of intelligent, responsive therapeutic platforms. As these innovations progress toward clinical translation, the vision of cancer treatment shifting from broadly systemic approaches to finely-tuned, patient-specific therapies becomes increasingly achievable.

Ultimately, the emergence of pH-responsive, charge-switching nanocarriers represents a significant leap toward integrating nanotechnology with molecular oncology, bringing personalized medicine from concept to practice. Such advances promise to alleviate the global health burden imposed by cancer, augmenting quality of life and survival rates for millions. As this exciting field evolves, continued interdisciplinary research will be essential to overcome challenges and unlock the full potential of these smart nanomaterials in precision medicine.

Subject of Research: Animals

Article Title: Polyglycerol-Grafted Graphene Oxide with pH-Responsive Charge-Convertible Surface to Dynamically Control the Nanobiointeractions for Enhanced in Vivo Tumor Internalization

News Publication Date: 1-Jun-2025

Web References: https://doi.org/10.1002/smll.202503029

Image Credits: Professor Yuta Nishina from Okayama University

Keywords: Health and medicine; Cancer; Cancer treatments; Nanomedicine; Cancer medication; Targeted drug delivery; Cancer immunology; Personalized medicine; Tumor regression; Drug interactions